Nodoka Sekiguchi

Publication Activity (10 Years)

Years Active: 2016-2020
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Tyrosine Kinase

Advanced Non Small Cell Lung Cancer

Top Venues

The Journal of dermatology

International journal of hematology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Nodoka Sekiguchi, Sae Kubota, Takuro Noguchi, Toshirou Fukushima, Takashi Kobayashi, Shintaro Kanda, Tomonobu Koizumi, Tomomi Miyake, Takushi Shirai, Ryuhei Okuyama
Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2-positive extramammary Paget's disease: Four cases and a review. The Journal of dermatology 47 (11) (2020)
Yuki Sato, Shiho Shirota, Yukiko Kiniwa, Nodoka Sekiguchi, Ryuhei Okuyama, Tomonobu Koizumi
Thymoma-associated graft-versus-host-like disease treated with high-dose i.v. immunoglobulin. The Journal of dermatology 46 (6) (2019)
Olli Dufva, Matti Kankainen, Tiina Kelkka, Nodoka Sekiguchi, Shady Adnan Awad, Samuli Eldfors, Bhagwan Yadav, Heikki Kuusanmäki, Disha Malani, Emma I Andersson, Paavo Pietarinen, Leena Saikko, Panu E Kovanen, Teija Ojala, Dean A Lee, Thomas P Loughran, Hideyuki Nakazawa, Junji Suzumiya, Ritsuro Suzuki, Young-Hyeh Ko, Won Seog Kim, Shih-Sung Chuang, Tero Aittokallio, Wing C Chan, Koichi Ohshima, Fumihiro Ishida, Mohamed El Missiry
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target. Nature communications 9 (1) (2018)
Nodoka Sekiguchi, Sayaka Nishina, Toru Kawakami, Hitoshi Sakai, Noriko Senoo, Yasushi Senoo, Toshiro Ito, Hiroshi Saito, Hideyuki Nakazawa, Tomonobu Koizumi, Fumihiro Ishida
Oral cyclophosphamide was effective for Coombs-negative autoimmune hemolytic anemia in CD16+CD56- chronic lymphoproliferative disorder of NK-cells. International journal of hematology 105 (6) (2016)